Ameriprise Financial Inc. boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 11.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,521,172 shares of the medical instruments supplier’s stock after buying an additional 160,818 shares during the period. Ameriprise Financial Inc. owned approximately 0.66% of DENTSPLY SIRONA worth $98,623,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in XRAY. BlackRock Inc. raised its holdings in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after purchasing an additional 13,457,730 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock valued at $330,488,000 after purchasing an additional 4,950,337 shares during the last quarter. Clearbridge Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after purchasing an additional 1,353,040 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of DENTSPLY SIRONA in the first quarter valued at about $64,184,000. Finally, Renaissance Technologies LLC raised its holdings in shares of DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock valued at $65,222,000 after purchasing an additional 742,700 shares during the last quarter. Hedge funds and other institutional investors own 93.87% of the company’s stock.

Several analysts have recently commented on the stock. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. HC Wainwright reiterated a “buy” rating and issued a $68.00 target price (down previously from $74.00) on shares of DENTSPLY SIRONA in a report on Monday, August 14th. Morgan Stanley increased their target price on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a report on Thursday, August 10th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a report on Thursday, July 13th. Finally, TheStreet downgraded shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $65.73.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 59.34 on Monday. DENTSPLY SIRONA Inc. has a 52-week low of $52.53 and a 52-week high of $65.68. The company’s market cap is $13.62 billion. The company’s 50-day moving average is $57.21 and its 200 day moving average is $61.78.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.65. The firm had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.76 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.59%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

TRADEMARK VIOLATION WARNING: This news story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/18/ameriprise-financial-inc-grows-holdings-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.